DICLOFENAC SODIUM TOPICAL GEL, 1% and HEPATIC ENZYME INCREASED

4,412 reports of this reaction

1.4% of all DICLOFENAC SODIUM TOPICAL GEL, 1% reports

#20 most reported adverse reaction

Overview

HEPATIC ENZYME INCREASED is the #20 most commonly reported adverse reaction for DICLOFENAC SODIUM TOPICAL GEL, 1%, manufactured by BluePoint Laboratories. There are 4,412 FDA adverse event reports linking DICLOFENAC SODIUM TOPICAL GEL, 1% to HEPATIC ENZYME INCREASED. This represents approximately 1.4% of all 323,718 adverse event reports for this drug.

Patients taking DICLOFENAC SODIUM TOPICAL GEL, 1% who experience hepatic enzyme increased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

HEPATIC ENZYME INCREASED4,412 of 323,718 reports

HEPATIC ENZYME INCREASED is a less commonly reported adverse event for DICLOFENAC SODIUM TOPICAL GEL, 1%, but still significant enough to appear in the safety profile.

Other Side Effects of DICLOFENAC SODIUM TOPICAL GEL, 1%

In addition to hepatic enzyme increased, the following adverse reactions have been reported for DICLOFENAC SODIUM TOPICAL GEL, 1%:

Other Drugs Associated with HEPATIC ENZYME INCREASED

The following drugs have also been linked to hepatic enzyme increased in FDA adverse event reports:

ABACAVIR SULFATEACETAMINOPHEN 325 MGACETAMINOPHEN AND CODEINEALCOHOLATOMOXETINECAFFEINECAFFEINE CITRATECLONIDINE HYDROCHLORIDEDICLOFENAC POTASSIUMDICLOFENAC POTASSIUM, FILM COATEDDICLOFENAC POTASSIUM TABLETSDICLOFENAC SODIUM 1%DICLOFENAC SODIUM TOPICALFOSAPREPITANTHAMAMELIS VIRGINIANA ROOT BARK/STEM BARKISOPROPYL ALCOHOLKETOPROFENMETHYL SALICYLATEMETHYLPREDNISOLONE ACETATENORTRIPTYLINE HYDROCHLORIDE

Frequently Asked Questions

Does DICLOFENAC SODIUM TOPICAL GEL, 1% cause HEPATIC ENZYME INCREASED?

HEPATIC ENZYME INCREASED has been reported as an adverse event in 4,412 FDA reports for DICLOFENAC SODIUM TOPICAL GEL, 1%. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is HEPATIC ENZYME INCREASED with DICLOFENAC SODIUM TOPICAL GEL, 1%?

HEPATIC ENZYME INCREASED accounts for approximately 1.4% of all adverse event reports for DICLOFENAC SODIUM TOPICAL GEL, 1%, making it a notable side effect.

What should I do if I experience HEPATIC ENZYME INCREASED while taking DICLOFENAC SODIUM TOPICAL GEL, 1%?

If you experience hepatic enzyme increased while taking DICLOFENAC SODIUM TOPICAL GEL, 1%, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

DICLOFENAC SODIUM TOPICAL GEL, 1% Full ProfileAll Drugs Causing HEPATIC ENZYME INCREASEDBluePoint Laboratories Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.